×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Aster DM Healthcare Limited | 6514.7 | 805.9 | 6130.4 | 1.57 | 33,103 | 93.6 |
| AJANTA PHARMA LTD. | 12491.9 | 2549.7 | 12085.6 | 20.4 | 31962 | 34.4 |
| Gland Pharma Limited | 10935.76 | 2692.58 | 10388.35 | 16.34 | 30943 | 40.2 |
Aster DM Healthcare Limited, with Security Code 540975, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 429.5 | 457.2 | 509.2 | 524.5 | 545.6 | 565.6 | 604.7 | 576.3 | 573.9 | 613.0 |
| Expenses | 344.0 | 374.2 | 423.2 | 433.0 | 446.1 | 464.3 | 475.7 | 465.1 | 458.9 | 479.5 |
| Operating Profit | 85.5 | 83.0 | 86.1 | 91.5 | 99.5 | 101.4 | 129.0 | 111.3 | 115.0 | 133.5 |
| OPM % | 19.9% | 18.16% | 16.9% | 17.45% | 18.24% | 17.92% | 21.33% | 19.31% | 20.03% | 21.78% |
| Other Income | 12.2 | 11.5 | 20.5 | 13.3 | 3.7 | 5,992.2 | 46.7 | 14.2 | 8.7 | 34.0 |
| Interest | 14.6 | 15.6 | 20.7 | 21.1 | 20.9 | 21.4 | 19.3 | 21.6 | 23.3 | 21.6 |
| Depreciation | 29.1 | 26.1 | 29.1 | 30.6 | 35.7 | 34.6 | 36.6 | 35.6 | 37.8 | 37.9 |
| Profit before tax | 54.1 | 52.8 | 56.7 | 53.2 | 46.7 | 5,664.8 | 119.8 | 91.5 | 89.1 | 112.4 |
| Tax % | -4% | 0% | 4.2% | 0% | -117.4% | -0.5% | 25% | -27.1% | -2.4% | 25.4% |
| Net Profit | 51.9 | 52.8 | 59.1 | 53.2 | -8.1 | 6,008.2 | 89.8 | 49.8 | 61.1 | 80.6 |
| EPS in Rs | 1.04 | 1.06 | 1.19 | 1.07 | -0.16 | 120.5 | 1.8 | 1 | 0 | 1.57 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,192.1 | 3,262.3 | 3,215.4 | 3,316.6 | 3,710.6 | 973.6 | 1,001.9 | 1,086.4 | 1,049.8 | 1,000.3 |
| Expenses | 2,743.5 | 2,756.7 | 2,835.0 | 2,946.7 | 3,154.9 | 817.1 | 841.0 | 869.3 | 864.2 | 818.2 |
| Operating Profit | 448.7 | 505.6 | 380.4 | 370.0 | 555.7 | 156.5 | 160.8 | 217.1 | 185.6 | 182.1 |
| OPM % | 14.06% | 15.5% | 11.83% | 11.15% | 14.98% | 16.07% | 16.05% | 19.99% | 17.68% | 18.2% |
| Other Income | 8.5 | 14.0 | 9.2 | -46.0 | 8.0 | 4.1 | 48.7 | 35.2 | 9.3 | 4.9 |
| Interest | 87.2 | 96.0 | 98.9 | 101.9 | 98.6 | 29.9 | 29.2 | 31.5 | 30.8 | 32.4 |
| Depreciation | 197.5 | 218.6 | 217.5 | 227.2 | 231.5 | 58.4 | 60.4 | 62.3 | 62.2 | 64.0 |
| Profit before tax | 172.5 | 205.1 | 73.3 | 49.5 | 233.5 | 72.3 | 120.0 | 158.7 | 125.6 | 117.0 |
| Tax % | -8.4% | -11.3% | -66.3% | -475.2% | -10% | -40.7% | 31.8% | -32.8% | 35.5% | -5% |
| Net Profit | 159.0 | 182.6 | 19.9 | -15.3 | 209.2 | -2.2 | 5,152.2 | 105.8 | 64.4 | 85.5 |
| EPS in Rs | 2.8 | 3.43 | 0.1 | -0.62 | 3.6 | -0.48 | 103.19 | 1.94 | 1.14 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 46% |
| 5 Years: | 25% |
| 3 Years: | 28% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 55% |
| 5 Years: | 149% |
| 3 Years: | 303% |
| TTM: | 3642% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 45% |
| 3 Years: | 48% |
| 1 Year: | 60% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | -14% |
| 3 Years: | -26% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | -2% |
| 3 Years: | -9% |
| TTM: | 209% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 45% |
| 3 Years: | 48% |
| 1 Year: | 60% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|